The drug-nitroxide radical hybrid-compound 7-N-((2,2,5,5-tetramethylpyrrolidine-1-yloxy(PROXYL))-3-yl-methyl)theophylline (3) was synthesized by coupling 7-N-tosyltheophylline with 3-hydroxymethyl-PROXYL, HMP). The stability of 3 relative to that of HMP was examined in the presence of the anti-oxidant, ascorbic acid (AsA). The initial reduction rate constants of 3 and HMP were 11.9±5.3 and 6.1±5.2 M−1 min−1, respectively. In the presence of glutathione (GSH), these constants increased slightly to 22.3±6.8 and 9.1±2.4 M−1 min−1, respectively. Two-dimensional cranial electron paramagnetic resonance imaging of mice intravenously injected with 3 via the tail vein revealed that probe 3 enters the mouse brain by passing through the blood–brain barrier (BBB).
药物-
氮氧自由基杂化化合物7-N-((
2,2,5,5-四甲基吡咯烷-1-基氧基(PROXYL))-3-基甲基)茶碱(3)是通过7-N-
甲苯磺酰基茶碱与3-羟甲基-PROXYL(HMP)的耦合反应合成的。在
抗氧化剂抗坏血酸(AsA)的存在下,研究了3相对于HMP的稳定性。3和HMP的初始还原速率常数分别为11.9±5.3和6.1±5.2 M−1 min−1。在
谷胱甘肽(GSH)的存在下,这些常数略有增加,分别为22.3±6.8和9.1±2.4 M−1 min−1。通过尾静脉静脉注射3的小鼠二维颅脑电子顺磁共振成像显示,探针3通过血脑屏障(BBB)进入小鼠大脑。